Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice

Journal of Clinical Investigation

Volumn 100, Issue 11, 1997, Pages 2729-2736

  Kulkarni, Rohit N ^a,c   Wang, Zhi Li ^a   Wang, Ren Ming ^a   Hurley, James D ^a   Smith, David M ^a   Ghatei, Mohammad A ^a   Withers, Dominic J ^a   Gardiner, James V ^a   Bailey, Cliff J ^b   Bloom, Stephen R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Insulin; Islet; Leptin; Suppression; cells

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; MESSENGER RNA; RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN RELEASE; INSULINOMA; MALE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RAT; TUMOR CELL CULTURE;

EID: 2642653233     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119818     Document Type: Article

References (49)

1. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman. 1994. Positional cloning of the mouse obese gene and its human homologue [published erratum appears in Nature. 1995. 374:479]. Nature. 372:425-432.
2. Schwartz, M.W., E. Peskind, M. Raskind, E.J. Boyko, and D. Porte, Jr. 1996. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat. Med. 2:589-593.
3. Considine, R.V., M.K. Sinha, M.L. Heiman, A. Kriauciunas, T.W. Stephens, M.R. Nyce, J.P. Ohannesian, C.C. Marco, L.J. McKee, T.L. Bauer, and J.F. Caro. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:292-295.
4. Halaas, J.L., K.S. Gajiwala, M. Maffei, S.L. Cohen, B.T. Chait, D. Rabinowitz, R.L. Lallone, S.K. Burley, and J.M. Friedman. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269: 543-546.
5. Pelleymounter, M.A., M.J. Cullen, M.B. Baker, R. Hecht, D. Winters, T. Boone, and F. Collins. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269:540-543.
6. Campfield, L.A., F.J. Smith, Y. Guisez, R. Devos, and P. Burn. 1995. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 269:546-549.
7. Gainsford, T., T.A. Willson, D. Metcalf, E. Handman, C. McFarlane, A. Ng, N.A. Nicola, W.S. Alexander, and D.J. Hilton. 1996. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc. Natl. Acad. Sci. USA. 93:14564-14568.
8. Cohen, B., D. Novick, and M. Rubinstein. 1996. Modulation of insulin activities by leptin. Science. 274:1185-1188.
9. Saladin, R., P. De Vos, M. Guerre Millo, A. Leturque, J. Girard, B. Staels, and J. Auwerx. 1995. Transient increase in obese gene expression after food intake or insulin administration. Nature. 377:527-529.
10. Malmstrom, R., M.R. Taskinen, S.L. Karonen, and H. Yki Jarvinen. 1996. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetalogia. 39:993-996.
11. Segal, K.R., M. Landt, and S. Klein. 1996. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes. 45: 988-991.
12. Kieffer, T.J., R.S. Heller, and J.F. Habener. 1996. Leptin receptors expressed on pancreatic beta-cells. Biochem. Biophys. Res. Commun. 224:522-527.
13. Emilsson, V., Y.L. Liu, M.A. Cawthorne, N.M. Morton, and M. Davenport. 1997. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes. 46:313-316.
14. Leclercq Meyer, V., R.V. Considine, A. Sener, and W.J. Malaisse. 1996. Do leptin receptors play a functional role in the endocrine pancreas? Biochem. Biophys. Res. Commun. 229:794-798.
15. Rentsch, J., N. Levens, and M. Chiesi. 1995. Recombinant ob-gene product reduces food intake in fasted mice. Biochem. Biophys. Res. Commun. 214:131-136.
16. Wang, Z.L., W.M. Bennet, M.A. Ghatei, P.G. Byfield, D.M. Smith, and S.R. Bloom. 1993. Influence of islet amyloid polypeptide and the 837 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes. 42:330-335.
17. Lacy, P.E., and M. Kostianovsky. 1967. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 16:35-39.
18. Bennet, W.M., Z.L. Wang, P.M. Jones, R.M. Wang, R.F. James, N.J. London, M.A. Ghatei, and S.R. Bloom. 1996. Presence of neuropeptide Y and its messenger ribonucleic acid in human islets: evidence for a possible paracrine role. J. Clin. Endocrinol. Metab. 81:2117-2120.
19. Albano, J.D., R.P. Ekins, G. Maritz, and R.C. Turner. 1972. A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol. Copenh. 70:487-509.
20. Knaack, D., D.M. Fiore, M. Surana, M. Leiser, M. Laurance, D. Fusco DeMane, O.D. Hegre, N. Fleischer, and S. Efrat. 1994. Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes. 43:1413-1417.
21. Kulkarni, R.N., Z.L. Wang, K.O. Akinsanya, W.M. Bennet, R.M. Wang, D.M. Smith, M.A. Ghatei, P.G. Byfield, and S.R. Bloom. 1995. Pyroglutamyl-phenylalanyl-proline amide attenuates thyrotropin-releasing hormone-stimulated insulin secretion in perifused rat islets and insulin-secreting clonal beta-cell lines. Endocrinology. 136:5155-5164.
22. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
23. Ferrier, G.J., A.M. Pierson, P.M. Jones, S.R. Bloom, S.I. Girgis, and S. Legon. 1989. Expression of the rat amylin (IAPP/DAP) gene. J. Mol. Endocrinol. 3:R14.
24. Smith, D.M., S.R. Bloom, M.C. Sugden, and M.J. Holness. 1992. Glucose transporter expression and glucose utilization in skeletal musele and brown adipose tissue during starvation and refeeding. Biochem. J. 282:231-235.
25. Tartaglia, L.A., M. Dembski, X. Weng, N. Deng, J. Culpepper, R. Devos, G.J. Richards, L.A. Campfield, F.T. Clark, J. Deeds, et al. 1995. Identification and expression cloning of a leptin receptor, OBR. Cell. 83:1263-1271.
26. Beak, S.A., C.J. Small, I. Ilovaiskaia, J.D. Hurley, M.A. Ghatei, S.R. Bloom, and D.M. Smith. 1996. Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): characterization of binding sites for GLP-1 on alpha-TSH cells. Endocrinology. 137:4130-4138.
27. 2+ and membrane potential in lymphocytes. Nature. 295:68-71.
28. 2+ in quiescent 3T3 cells stimulated by platelet-derived growth factor, bombesin and vasopressin. EMBO (Eur. Mol. Biol. Organ.) J. 7:2741-2747.
29. Wang, Z., R.M. Wang, A.A. Owji, D.M. Smith, M.A. Ghatei, and S.R. Bloom. 1995. Glucagon-like peptide-1 is a physiological incretin in rat. J. Clin. Invest. 95:417-421.
30. Ghilardi, N., S. Ziegler, A. Wiestner, R. Stoffel, M.H. Heim, and R.C. Skoda. 1996. Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. USA. 93:6231-6235.
31. Ahima, R.S., D. Prabakaran, C. Mantzoros, D. Qu, B. Lowell, E. Maratos Flier, and J.S. Flier. 1996. Role of leptin in the neuroendocrine response to fasting. Nature. 382:250-252.
32. Coleman, D.L. 1978. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia. 14:141-148.
33. Hardie, L.J., D.V. Rayner, S. Holmes, and P. Trayhurn. 1996. Circulating leptin levels are modulated by fasting, cold exposure and insulin administration in lean but not Zucker (fa/fa) rats as measured by ELISA. Biochem. Biophys. Res. Commun. 223:660-665.
34. Bennett, B.D., G.P. Solar, J.O. Yuan, J. Mathias, G.R. Thomas, and W. Matthews. 1996. A role for leptin and its cognate receptor in hematopoiesis. Curr. Biol. 6:1170-1180.
35. Sinha, M.K., I. Opentanova, J.P. Ohannesian, J.W. Kolaczynski, M.L. Heiman, J. Hale, G.W. Becker, R.R. Bowsher, T.W. Stephens, and J.F. Caro. 1996. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term lasting. J. Clin. Invest. 98:1277-1282.
36. Yu, W.H., M. Kimura, A. Walczewska, S. Karanth, and S.M. McCann. 1997. Role of leptin in hypothalamic-pituitary function. Proc. Natl. Acad. Sci. USA. 94:1023-1028.
37. Kieffer, T.J., R.S. Heller, C.A. Leech, G.G. Holz, and J.F. Habener. 1997. Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic β cells. Diabetes. 46:1087-1093.
38. Shimabukuro, M., K. Koyama, G. Chen, M.-Y. Wang, F. Trieu, Y. Lee, C.B. Newgard, and R.H. Unger. 1997. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. USA. 94:4637-4641.
39. Frederich, R.C., A. Hamann, S. Anderson, B. Lollmann, B.B. Lowell, and J.S. Flier. 1995. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 1:1311-1314.
40. Maffei, M., J. Halaas, E. Ravussin, R.E. Pratley, G.H. Lee, Y. Zhang, H. Fei, S. Kim, R. Lallone, S. Ranganathan, et al. 1995. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1:1155-1161.
41. Truett, G.E., N. Bahary, J.M. Friedman, and R.L. Leibel. 1991. Rat obesity gene fatty (fa) maps to chromosome 5: evidence for homology with the mouse gene diabetes (db). Proc. Natl. Acad. Sci. USA. 88:7806-7809.
42. Sinha, M.K., J.P. Ohannesian, M.L. Heiman, A. Kriauciunas, T.W. Stephens, S. Magosin, C. Marco, and J.F. Caro. 1996. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J. Clin. Invest. 97:1344-1347.
43. Levin, N., C. Nelson, A. Gurney, R. Vandlen, and F. de Sauvage. 1996. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc. Natl. Acad. Sci. USA. 93:1726-1730.
44. Iida, M., T. Murakami, K. Ishida, A. Mizuno, M. Kuwajima, and K. Shima. 1996. Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker fatty (fa/fa) rat. Biochem. Biophys. Res. Commun. 222:19-26.
45. Stephens, T.W., M. Basinski, P.K. Bristow, J.M. Bue Valleskey, S.G. Burgett, L. Craft, J. Hale, J. Hoffmann, H.M. Hsiung, A. Kriauciunas, et al. 1995. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 377:530-532.
46. Schwartz, M.W., D.G. Baskin, T.R. Bukowski, J.L. Kuijper, D. Foster, G. Lasser, D.E. Prunkard, D. Porte, Jr., S.C. Woods, R.J. Seeley, and D.S. Weigle. 1996. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 45:531-535.
47. Steinberg, D. 1992. The endocrine pancreas. In The Physiological Basis of Medical Practice. J.B. West, editor. Williams and Wilkins, Baltimore. 760-763.
48. Shi, C.L., J. Sehlin, I.E. Taljedal, N.G. Morgan, and W. Montague. 1985. Effects of UK-14,304, noradrenaline, and propranolol on insulin release from transplanted mouse islets. Studies on the mechanism of inhibition of glucose-stimulated insulin secretion by noradrenaline in rat islets of Langerhans. Eur. J. Endocrinol. 226:571-576.
49. Cooney, G.J., M.A. Vanner, J.L. Nicks, P.P. Williams, and I.D. Caterson. 1989. Changes in the lipogenic response to feeding of liver, white adipose tissue and brown adipose tissue during the development of obesity in the gold-thioglucose-injected mouse. Biochem. J. 259:651-657.